Changing Fibroid Treatment Protocols: Reactions to FDA Warnings on Power Morcellation episode artwork

EPISODE · Mar 9, 2015 · 17 MIN

Changing Fibroid Treatment Protocols: Reactions to FDA Warnings on Power Morcellation

from Clinician's Roundtable

Host: Matt Birnholz, MD The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.

Episode metadata supplied by the publisher feed · Published Mar 9, 2015

Embed this episode

NOW PLAYING

Changing Fibroid Treatment Protocols: Reactions to FDA Warnings on Power Morcellation

0:00 17:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinician's Roundtable?

This episode is 17 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on March 9, 2015.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!